Owen Garrick - Amarantus Bioscience Co Advisor

AMBS Stock  USD 0.0001  0.00  0.00%   

Insider

Owen Garrick is Co Advisor of Amarantus Bioscience Holdings
Phone650-862-5391
Webhttps://www.amarantus.com

Similar Executives

Found 8 records

INSIDER Age

George HillAscletis Pharma
72
Hejingdao WuAscletis Pharma
49
John MBAAscletis Pharma
N/A
Yuemei YanAscletis Pharma
53
Jinzi WuAscletis Pharma
60
Handan HeAscletis Pharma
61
Kristjan GudmundssonAscletis Pharma
55
Ming CPAAscletis Pharma
N/A
Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Amarantus Bioscience operates under Biotechnology classification in the United States and is traded on OTC Exchange. Amarantus Bioscience Holdings [AMBS] is a Pink Sheet which is traded between brokers over the counter.

Amarantus Bioscience Leadership Team

Elected by the shareholders, the Amarantus Bioscience's board of directors comprises two types of representatives: Amarantus Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amarantus. The board's role is to monitor Amarantus Bioscience's management team and ensure that shareholders' interests are well served. Amarantus Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amarantus Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Paula MD, Chief Diagnostics
Elise MS, VP Management
Aimee Boutcher, Director Relations
Robert Harris, Compliance Officer, Independent Director, Chairman of Governance and Nominating Committee, Member of Compensation Committee and Member of Audit Committee
John Commissiong, Chief Scientific Officer, Director and Member of Scientific Advisory Board
Brian Harvey, Chief Advisors
Owen Garrick, Co Advisor
Richard MD, Chief Corp
Gerald Commissiong, CEO and President and Director
Ravi Kiron, Sr Devel

Amarantus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Amarantus Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Amarantus Pink Sheet Analysis

When running Amarantus Bioscience's price analysis, check to measure Amarantus Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amarantus Bioscience is operating at the current time. Most of Amarantus Bioscience's value examination focuses on studying past and present price action to predict the probability of Amarantus Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amarantus Bioscience's price. Additionally, you may evaluate how the addition of Amarantus Bioscience to your portfolios can decrease your overall portfolio volatility.

Trending Assets

AKESF
Akeso, Inc
7.05  -0.14  -1.95 
AVXT
Avax Techs
0.00  0.00  0.00 
ADYX
Adynxx Inc
0.0001  0.00  0.00 
ADILW
Adial Pharmaceuticals
0.01  0  52.50 
News Freq…Investor S…